Identification of Mutations That Lead to Aplasia Cutis Congenita in Families and Isolated Cases and Studies of Cellular and Molecular Mechanisms
概览
- 阶段
- 不适用
- 干预措施
- affected, unaffected
- 疾病 / 适应症
- Aplasia Cutis Congenita
- 发起方
- UConn Health
- 入组人数
- 600
- 试验地点
- 1
- 主要终点
- Identification of genetic elements
- 状态
- 招募中
- 最后更新
- 17天前
概览
简要总结
The goal of this research study is to identify genes and regulatory elements on chromosomes that cause ACC. The investigators also study tissue samples from patients to learn about the processes that lead to this disorder.
详细描述
Aplasia cutis congenita (ACC) or congenital scalp defect is a very rare disorder that affects bone and skin. The definition for ACC is the localized absence of (normal) skin at the time of birth (congenital). The skin appears thinner and the underlying structures are visible. We study mostly the isolated form of ACC with the lesion often being at the vertex of the skull (at or close to the top of the skull). The bone underlying the lesion is sometimes thinner as well. For this study we will: * Send out study participation kits and consent by phone * Collect a saliva sample from eligible individuals * Obtain information regarding ACC * Document disorder with photos and doctor's letters * If patients undergo surgery for ACC we ask to obtain some tissue that would otherwise be discarded * Isolate DNA from the saliva sample * Perform genetic analyses of the DNA with the most up-to-date methods available to identify genetic variations * Study in the laboratory why the genetic variations cause the disorder
研究者
Ernst Reichenberger
Assoc. Prof.
UConn Health
入排标准
入选标准
- •ACC; unaffected individuals only if part of a participating ACC family
排除标准
- •No ACC unaffected individuals only as part of a participating ACC family
研究组 & 干预措施
affected, unaffected
Individuals with diagnosed ACC
结局指标
主要结局
Identification of genetic elements
时间窗: at time of identification
The goal is to identify relevant genes or genetic elements that cause the disease or contribute to the disease progression and severity.